Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease
β Scribed by William F. Stenson; Joshua R. Korzenik
- Book ID
- 110086058
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 72 KB
- Volume
- 8
- Category
- Article
- ISSN
- 1078-0998
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Background: Protection against vaccine-preventable diseases is important in inflammatory bowel disease (IBD) because of increased susceptibility and severity of infection with immunosuppressive therapy. However, immunosuppressive therapy may affect vaccine response. This study aimed to evaluate immu
## Background: Inflammatory bowel diseases (ibds) are a result of interactions between luminal pathogens and the intestinal immune response. cyclooxygenase-2 (cox-2) plays a key role in the regulation of the inflammatory response upon stimulation by luminal pathogens via toll-like receptors. ## Me